Compositions for a dietary supplement to manage senescent cells
US-2024390346-A1 · Nov 28, 2024 · US
US9314493B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9314493-B2 |
| Application number | US-201213565224-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2012 |
| Priority date | May 28, 2007 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.
Opening claim text (preview).
What is claimed is: 1. A method for treating sexual dysfunction of a male subject, comprising: administering an effective amount of a ginseng berry extract to a male subject in need thereof, wherein the ginseng berry extract contains ginsenosides, wherein the ginsenosides consist of ginsenosides Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1, and Rg2; wherein the effective amount of the ginseng berry extract is 1-100 mg/kg body weight of the subject. 2. The method according to claim 1 , wherein the method further comprises administering an effective amount of L-arginine to the male subject. 3. The method according to claim 1 , wherein the method increases generation of nitric oxide (NO) in the vascular cells of the male subject. 4. The method according to claim 1 , wherein the method erects a penis of the male subject. 5. The method according to claim 1 , wherein the ginseng berry extract comprises 33.42 wt% of the total ginsenosides based on the total weight of the extract.
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Drugs for disorders of the cardiovascular system · CPC title
for impotence · CPC title
Magnoliopsida [dicotyledons] · CPC title
Anti-ageing preparations · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.